In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- North Rockhampton high school student tests positive for tuberculosis, contact tracing underwayon October 8, 2020 at 10:33 pm
Contact tracing is underway after a Rockhampton high school student was diagnosed with tuberculosis and attended school while infectious.
- 'Worrying' rise of tuberculosis cases in Shropshireon October 8, 2020 at 10:19 pm
A "worrying" rise in numbers of people being diagnosed with tuberculosis has been recorded, new figures for Shropshire and Telford & Wrekin revealed.
- Mass contact tracing underway after Rockhampton teen diagnosed with tuberculosison October 8, 2020 at 9:46 pm
A Rockhampton student has been diagnosed with a deadly infectious disease, sparking a mass contact tracing operation by health authorities.
- Rockhampton teen diagnosed with tuberculosison October 8, 2020 at 9:19 pm
The Central Queensland Hospital and Health Service announced the tuberculosis (TB) case at a press conference at 1pm today. The student attends North Rockhampton High School and contact tracing was ...
- Prisoner contracts tuberculosison October 6, 2020 at 10:56 am
"Unfortunately, medical information is not readily given out to staff, and it's a concern of ours that somebody comes in with something transferrable via the atmosphere, and we don't know about it ...
- Canadian researchers begin clinical trials of tuberculosis vaccine for COVID-19on October 6, 2020 at 7:09 am
Researchers in Canada are hoping a century-old vaccine designed to treat tuberculosis can become the key to fighting off a COVID-19 infection.
- Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosison October 6, 2020 at 6:14 am
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule ...
- Health and safety review under way after Tuberculosis case in Waikato prisonon October 5, 2020 at 9:37 pm
There is at least one case of tuberculosis, known as TB, in the Spring Hill prison in North Waikato. Spring Hill Prison director Megan Tuhoro said the secure and controlled nature of the prison ...
- Latent Tuberculosis Infection (LTBI) Testing Market Will Expand at 5.6% CAGR to Cross $ 1540 million by 2025on September 30, 2020 at 9:02 am
Selbyville, Delaware, The ‘ Latent Tuberculosis Infection (LTBI) Testing market’ research report now available ...
- Actor Farooque diagnosed with tuberculosison September 29, 2020 at 5:00 pm
National award winning film actor and ruling Awami League lawmaker Akbar Hossain Pathan, popularly known as Farooque in the screen, has been diagnosed with tuberculosis. The veteran actor of ...
via Google News and Bing News